Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Stephan Brand

5PUBLICATIONS

1CO-AUTHORS

Immunogenetics (incl. genetic immunology)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Innate immunity

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (5)

Sort by Publication Date:

|Jan 09, 2025

Editorial: Individualising JAK Inhibitor Selection for Patients With Ulcerative Colitis.

Simon Woelfel, Stephan Brand

|Nov 19, 2024

Editorial: Updated COVID-19 Boosters-Tailoring Protection for Patients With IBD. Authors' Reply.

Simon Woelfel, Stephan Brand

|Oct 29, 2024

XBB.1.5-Adapted COVID-19 mRNA Vaccines but Not Infections With Previous Omicron Variants Boost Neutralisation Against the SARS-CoV-2 JN.1 Variant in Patients With Inflammatory Bowel Disease.

Simon Woelfel, Joel Dütschler, Daniel Junker

|Aug 12, 2023

STAR SIGN study: Evaluation of COVID-19 vaccine efficacy against the SARS-CoV-2 variants BQ.1.1 and XBB.1.5 in patients with inflammatory bowel disease.

Simon Woelfel, Joel Dütschler, Marius König

|Oct 29, 2022

Systemic and T cell-associated responses to SARS-CoV-2 immunisation in gut inflammation (STAR SIGN study): effects of biologics on vaccination efficacy of the third dose of mRNA vaccines against SARS-CoV-2.

Simon Woelfel, Joel Dütschler, Marius König

Pageof 1

Frequent Collaborators

4 joint publications

Simon Woelfel

Frequent Collaborators

4 joint publications

Simon Woelfel

Top Related Videos

Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3

Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3

Published on : Apr 07, 2023

In Vivo Augmentation of Gut-Homing Regulatory T Cell Induction

In Vivo Augmentation of Gut-Homing Regulatory T Cell Induction

Published on : Jan 22, 2020

Induction of Intestinal Inflammation by Adoptive Transfer of CBir1 TCR Transgenic CD4<sup>+</sup> T Cells to Immunodeficient Mice

Induction of Intestinal Inflammation by Adoptive Transfer of CBir1 TCR Transgenic CD4<sup>+</sup> T Cells to Immunodeficient Mice

Published on : Dec 16, 2021

See more related videos

Top Related Videos

Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3

Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3

Published on : Apr 07, 2023

In Vivo Augmentation of Gut-Homing Regulatory T Cell Induction

In Vivo Augmentation of Gut-Homing Regulatory T Cell Induction

Published on : Jan 22, 2020

Induction of Intestinal Inflammation by Adoptive Transfer of CBir1 TCR Transgenic CD4<sup>+</sup> T Cells to Immunodeficient Mice

Induction of Intestinal Inflammation by Adoptive Transfer of CBir1 TCR Transgenic CD4<sup>+</sup> T Cells to Immunodeficient Mice

Published on : Dec 16, 2021

See more related videos